| 10858322 |
Process for preparing 1-isobutyryl-1′-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[D]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-one |
Weihua Shi, Zheng Wang, Weidong Li, Linghui Wu, Hongwei Li +4 more |
2020-12-08 |
| 10793845 |
Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
Nikolaj Spodsberg, Tarana Shaghasi, Matt Sweeney, Kirk Matthew Schnorr |
2020-10-06 |
| 10696681 |
Process for preparing beta 3 agonists and intermediates |
Zhuqing Liu, Richard Desmond, Jeonghan Park, Alexei Kalinin, Birgit Kosjek +3 more |
2020-06-30 |
| 10662144 |
Method of reducing color in alkanolamine compositions and compositions produced thereby |
Flaiyh Al-Anazi |
2020-05-26 |
| 10633347 |
Crystal form B of 1-isobutyryl-1′-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[d]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-one |
Weihua Shi, Zheng Wang, Weidong Li, Linghui Wu, Hongwei Li +4 more |
2020-04-28 |
| 10577316 |
Process for making beta 3 agonists and intermediates |
John Y. L. Chung, Kevin R. Campos, Edward Cleator, Robert F. Dunn, Andrew Gibson +9 more |
2020-03-03 |
| 10570431 |
Compositions comprising a polypeptide having cellulolytic enhancing activity and a heterocyclic compound and uses thereof |
Jason Quinlan, Matthew Sweeney |
2020-02-25 |
